Jan 3, 2010

Vaughan Williams Classification of Anti-arrythmic Drugs

Class Action Drugs Caution
Ia

Sodium channel inhibition: prolong
repolarization

Quinidine, procainamide,
disopyramide

myocardial infarction, congestive
heart failure,
renal disease

Ib

Sodium channel inhibition: shorten
repolarization

Lidocaine

Proarrhythmias

Ic

Sodium channel inhibition: no effect on repolarization but reduce conductivity

Flecainide, propafenone

Structural heart disease, myocardial infarction, congestive heart failure

II

B-Adrenergic inhibition

Timolol, esmolol, atenolol, bisoprolol

Acute heart failure, bronchospasm

III

Potassium channel inhibition: prolong repolarization

Amiodarone, sotalol

Renal disease, pulmonary disease

IV

Calcium channel inhibition

Verapamil, diltiazem

Not in conjunction with B-blockers

Misc

Na-K ATPase inhibition: potentiate
parasympathetic response

Digoxin

Renal disease, hypokalemia

No comments:

Post a Comment